
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE
("GSC" or the "Company")
Director/PDMR Shareholdings
Director |
Shares sold |
Shares acquired |
Total holding following notification |
% of issued Ordinary share capital |
|
428,481 |
428,481 |
1,477,777 |
0.26% |
Enquiries:
|
|
|
+44 (0)20 4582 3500 |
|
|
SI Capital Limited |
|
|
+44 (0)14 8341 3500 |
|
|
BlytheRay |
|
|
+44 (0) 20 7138 3204 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities/ person closely associated with them.
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||||
a) |
|
|
|||||||||
2 |
Reason for the notification |
||||||||||
a) |
Position/status |
Non-Executive Director |
|||||||||
b) |
Initial notification/ Amendment |
Initial Notification |
|||||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||
a) |
|
|
|||||||||
b) |
LEI |
213800RF6N9WA8PZH313 |
|||||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of
GB00BLB5BF24 |
|||||||||
b) |
Nature of the transaction
|
A. Sales of shares from share dealing account B. Repurchase of ordinary shares into ISA account
|
|||||||||
c) |
Price(s) and volume(s)
|
|
|||||||||
d) |
Aggregated information A. Sales B. Repurchase
|
|
|||||||||
e) |
Date of the transaction
|
|
|||||||||
f) |
Place of the transaction |
|
About
Further information on the Company is available on the Company's website: https://gscplc.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the